Steroid-free immunosuppression

被引:1
作者
Kelly, Deirdre [1 ]
机构
[1] Birmingham Childrens Hosp NHS Trust, Liver Unit, Birmingham B4 6NH, W Midlands, England
关键词
paediatric liver transplantation; steroid-free immunosuppression;
D O I
10.1097/01.mot.0000244654.67544.54
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of review Long-term survival in paediatric liver transplantation has focused attention on morbidity related to immunosuppression and-the need to reduce dependence on calcineurin inhibitors and corticosteroid steroids. Recent findings This review summarizes lessons learnt from paediatric and adult liver and renal transplantation in the use of steroid-free induction, withdrawal or minimization. Large randomized studies in adult liver and renal transplantation have indicated that rejection rates are similar on steroid-free protocols compared with either historical or randomized controls. There are significant differences in infection rates, new onset diabetes mellitus, hypertension and hyperlipidaemia, but 2- and 5-year patient and graft survival were similar, indicating that steroid avoidance was possible with the use of IL-2 receptor antibody protocols. The severity of and fibrosis rate in hepatitis C disease is less on steroid-free regimes. There was no clear effect on the development of other allorecognition or tolerance. Summary Steroid minimization is advantageous for paediatric practice and is safe and effective in the short term. Large-scale paediatric randomized studies are required to evaluate the long-term efficacy of these regimes and the use of IL-2 antibodies on the development of chronic rejection, infection, including posttransplant lymphoproliferative disease, and the development of tolerance.
引用
收藏
页码:532 / 536
页数:5
相关论文
共 25 条
[11]   Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications:: Results from a prospective multicenter randomized study [J].
Lladó, L ;
Xiol, X ;
Figueras, J ;
Ramos, E ;
Memba, R ;
Serrano, T ;
Torras, J ;
Garcia-Gil, A ;
Gonzalez-Pinto, I ;
Castellote, J ;
Baliellas, C ;
Fabregat, J ;
Rafecas, A .
JOURNAL OF HEPATOLOGY, 2006, 44 (04) :710-716
[12]   Steroid preservation: the rationale for continued prescribing [J].
Marks, SD ;
Trompeter, RS .
PEDIATRIC NEPHROLOGY, 2006, 21 (03) :305-307
[13]   Prednisone-free maintenance immunosuppression - A 5-year experience [J].
Matas, AJ ;
Kandaswamy, R ;
Gillingham, KJ ;
McHugh, L ;
Ibrahim, H ;
Kasiske, B ;
Humar, A .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) :2473-2478
[14]   Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation [J].
Pelletier, SJ ;
Vanderwall, K ;
Debroy, MA ;
Englesbe, MJ ;
Sung, RS ;
Magee, JC ;
Fontana, RJ ;
Punch, JD .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :1214-1216
[15]  
Perkins J, 2006, LIVER TRANSPLANT, V12, P160
[16]   Steroid-free liver transplantation in children [J].
Reding, R ;
Gras, J ;
Sokal, E ;
Otte, JB ;
Davies, HFS .
LANCET, 2003, 362 (9401) :2068-2070
[17]   What is the best immunosuppression in living donor liver transplantation? [J].
Ringe, B ;
Moritz, M ;
Zeldin, G ;
Soriano, H .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (05) :2169-2171
[18]  
SALECO M, 2002, HEPATOLOGY, V35, P349
[19]   Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients [J].
Silverstein, DM ;
Aviles, DH ;
LeBlanc, PM ;
Jung, FF ;
Vehaskari, VM .
PEDIATRIC TRANSPLANTATION, 2005, 9 (05) :589-597
[20]   Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8+CD28-T-suppressor cells [J].
Sindhi, R ;
Manavalan, JS ;
Magill, A ;
Suciu-Foca, N ;
Zeevi, A .
HUMAN IMMUNOLOGY, 2005, 66 (03) :252-257